amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
Drug data last refreshed 20h ago · AI intelligence enriched 23h ago
AMINOSYN II 7% W/ ELECTROLYTES is a sterile injectable amino acid solution with electrolytes (magnesium, potassium, sodium, phosphate) designed for intravenous nutritional support. It provides essential amino acids and electrolytes for patients requiring parenteral nutrition, particularly those unable to tolerate oral or enteral feeding. The formulation supports protein synthesis and metabolic function in critically ill, post-surgical, and nutritionally compromised patients.
Late-stage product with moderate competitive pressure (30%) indicates stable but maturing market; manufacturing and regulatory teams will focus on lifecycle management and cost optimization.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on AMINOSYN II positions you in manufacturing, quality, and operations leadership within a stable, mature product with consistent hospital demand and no imminent generic threat. Career progression emphasizes technical expertise, operational excellence, and regulatory mastery in injectable manufacturing rather than commercial or promotional roles.
Worked on AMINOSYN II 7% W/ ELECTROLYTES at ICU Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
25 open roles linked to this drug
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo